BC
Black Canyon Bio
The startup develops a precision medicine platform that utilizes genomic analysis and machine learning algorithms to identify mutations that form neo-antigens in solid tumors. This technology enables the production of personalized adoptive cell therapies and cancer vaccines, addressing the limitations of first-generation cell therapies in treating cancer effectively.
- Artificial Intelligence
- Biotechnology
- Healthcare Technology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a precision medicine platform that utilizes genomic analysis and machine learning algorithms to identify mutations that form neo-antigens in solid tumors. This technology enables the production of personalized adoptive cell therapies and cancer vaccines, addressing the limitations of first-generation cell therapies in treating cancer effectively.